{
    "organizations": [],
    "uuid": "90032526bada45a9162aa67ba5471e5d85bf14b5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alder-biopharma-q4-loss-per-share/brief-alder-biopharma-q4-loss-per-share-0-80-idUSASB0C7J1",
    "ord_in_thread": 0,
    "title": "BRIEF-Alder Biopharma Q4 Loss Per Share $0.80",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Alder Biopharmaceuticals Inc:\n* ALDER BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND OPERATING RESULTS\n* Q4 LOSS PER SHARE $0.80 * ‍BIOLOGICS LICENSE APPLICATION (BLA) ON TRACK FOR SUBMISSION IN 2H18​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T05:44:00.000+02:00",
    "crawled": "2018-02-27T14:50:14.042+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "alder",
        "biopharmaceuticals",
        "inc",
        "alder",
        "biopharmaceuticals",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "operating",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "license",
        "application",
        "bla",
        "track",
        "submission",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}